Medtronic Unveils Biopsy System
Medtronic has launched the GenCut core biopsy system for lung tissue collection, following receipt of FDA 510(k) clearance in April.
The device, which is meant to be used in conjunction with the company’s superDimension navigation system, enables sample gathering from lesions deep inside the lungs, the Irish devicemaker claims.
The product features a shearing blade designed to collect larger and more intact samples, so that doctors can sample in one pass.
According to the American Lung Association, lung cancer is the leading cause of cancer-related deaths in the U.S. In its early stages, the disease presents few, if any symptoms, making diagnosis difficult until it enters later stages where long-term survival isn’t likely. — Jason Scott